Risk of Pneumonectomy After Induction Therapy for Locally Advanced Non-Small Cell Lung Cancer

Annals of Thoracic Surgery

Volumn 88, Issue 4, 2009, Pages 1079-1085

  d'Amato, Thomas A ^a   Ashrafi, Ahmad S ^b   Schuchert, Matthew J ^a   Alshehab, Derar S A ^c   Seely, Andrew J E ^c   Shamji, Farid M ^c   Maziak, Donna E ^c   Sundaresan, Sudhir R ^c   Ferson, Peter F ^a   Luketich, James D ^a   Landreneau, Rodney J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b St Catharines General Site   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; GEMCITABINE; IRINOTECAN; NAVELBINE; PACLITAXEL; VINBLASTINE; VINCRISTINE;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; BRONCHOPLEURAL FISTULA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CONTROLLED STUDY; EMPYEMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEART ARRHYTHMIA; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; RISK ASSESSMENT; SIDE EFFECT; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ODDS RATIO; ONTARIO; PENNSYLVANIA; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 70349170589     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.06.025     Document Type: Article

References (25)

1. Albain K.S., Rusch V.W., Crowley J.J., et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13 (1995) 1880-1892
2. Albain K.S., Swann R.S., Rusch V.R., et al. Phase III study of concurrent chemotherapy and radiotherapy versus chemotherapy and radiotherapy followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer: outcomes update of the North American Intergroup trial 0139. [abstract]. Proc Am Soc Clin Oncol 23 Suppl (2005) 624
3. Bueno R., Richards W.G., Swanson S.J., et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 70 (2000) 1826-1831
4. Alberts W.M. Diagnosis and management of lung cancer: executive summary. ACCP evidence-based clinical practice guidelines, 2nd edition. Chest 132 Suppl (2007) 1-19
5. Pisters K., Vallieres E., Bunn P.A., et al. S9900: surgery alone or surgery plus induction (ind) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC). Follow-up on a phase III trial. [abstract]. J Clin Oncol 25 Suppl 18 (2007) 389
6. Pisters K., Vallieres E., Bunn P., et al. S9900: a phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): preliminary results. [abstract]. J Clin Oncol 23 Suppl 16 (2005) 624
7. Fowler W.C., Langer C.J., Curran W.J., and Keller S.M. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 55 (1993) 986-989
8. Roth J.A., Fossella F., Komaki R., et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 86 (1994) 650-651
9. Roth J.A., Atkinson E.N., Fossella F., et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. Lung Cancer 21 (1998) 1-6
10. Martin J., Ginsberg R.J., Abolhoda A., et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg 72 (2001) 1149-1154
11. Darling G.E., Abdurahman A., Yi Q.L., et al. Risk of a right pneumonectomy: role of bronchopleural fistula. Ann Thorac Surg 79 (2005) 433-437
12. Eberhardt W., Wilke H., Stamatis G., et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small cell lung cancer: mature results of a phase II trial. J Clin Oncol 16 (1998) 622-634
13. Doddoli C., Thomas P., Thirion X., et al. Postoperative complications in relation with induction therapy for lung cancer. Eur J Cardiothoac Surg 20 (2001) 385-390
14. Cerfolio R.J., Bryant A.S., Spencer S.A., and Bartolucci A.A. Pulmonary resection after high dose and low dose chest irradiation. Ann Thorac Surg 80 (2005) 1224-1230
15. Mansour Z., Kochetkova E.A., Ducrocq X., et al. Induction chemotherapy does not increase the operative risk of pneumonectomy!. Eur J Cardiothorac Surg 32 (2007) 550
16. Alifano M., Boudaya M.S., Salvi M., et al. Pneumonectomy after chemotherapy: morbidity, mortality and long-term outcome. Ann Thorac Surg 85 (2008) 1866-1873
17. Gudbjartsson T., Gyllstedt E., Pikwer A., and Jönsson P. Early surgical results after pneumonectomy for nonsmall-cell lung cancer are not affected by preoperative radiotherapy and chemotherapy. Ann Thorac Surg 86 (2008) 376-382
18. Sonett J.R., Suntharalingam M., Edelman M.J., et al. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in nonsmall-cell lung cancer. Ann Thorac Surg 78 (2004) 1200-1206
19. Fujita S., Katakami N., Takahashi Y., et al. Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancer. Eur J Cardiothorac Surg 29 (2006) 896-901
20. Fowler W.C., Langer C.J., Curran W.J., and Keller S.M. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 55 (1993) 986-989
21. Novoa N., Varela G., and Jiménez M.F. Morbidity after surgery for non-small cell lung carcinoma is not related to neoadjuvant chemotherapy. Eur J Cardiothorac Surg 20 (2001) 700-704
22. Brouchet L., Bauvin E., Marcheix B., et al. Impact of induction treatment on postoperative complications in the treatment of non-small cell lung cancer. J Thorac Oncol 2 (2007) 626-631
23. Alexiou C., Beggs D., Rogers M.L., et al. Pneumonectomy for non-small cell lung cancer: predictors of operative mortality and survival. Eur J Cardiothorac Surg 20 (2001) 476-480
24. Leo F., Solli P., Veronesi G., et al. Does chemotherapy increase the risk of respiratory complications after pneumonectomy?. J Thorac Cardiovasc Surg 132 (2006) 519-523
25. Dyszkiewicz W., Pawlak K., and Gasiorowski L. Early post-pneumonectomy complications in the elderly. Eur J Cardiothorac Surg 17 (2000) 246-250